Literature DB >> 11123252

Cardiac expression of a gain-of-function alpha(5)-integrin results in perinatal lethality.

M L Valencik1, J A McDonald.   

Abstract

Communication between the extracellular matrix and the intracellular signal transduction and cytoskeletal system is mediated by integrin receptors. alpha(5)beta(1)-Integrin and its cognate ligand fibronectin are essential in development of mesodermal structures, myocyte differentiation, and normal cardiac development. To begin to explore the potential roles of alpha(5)beta(1)-integrin specifically in cardiomyocytes, we used a transgenic expression strategy. We overexpressed two forms of the human alpha(5)-integrin in cardiomyocytes: the full-length wild-type alpha(5)-integrin and a putative gain-of-function mutation created by truncating the cytoplasmic domain, designated alpha(5-1)-integrin. Overexpression of the wild-type alpha(5)-integrin has no detectable adverse effects in the mouse, whereas expression of alpha(5-1)-integrin caused electrocardiographic abnormalities, fibrotic changes in the ventricle, and perinatal lethality. Thus physiological regulation of integrin function appears essential for maintenance of normal cardiomyocyte structure and function. This strengthens the role of inside-out signaling in regulation of integrins in vivo and suggests that integrins and associated signaling molecules are important in cardiomyocyte function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123252     DOI: 10.1152/ajpheart.2001.280.1.H361

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin.

Authors:  Vandana Sarin; Robert D Gaffin; Gerald A Meininger; Mariappan Muthuchamy
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

Review 2.  A potential role for integrin signaling in mechanoelectrical feedback.

Authors:  Borna E Dabiri; Hyungsuk Lee; Kevin Kit Parker
Journal:  Prog Biophys Mol Biol       Date:  2012-07-20       Impact factor: 3.667

Review 3.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

4.  Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophy.

Authors:  Laura A DiMichele; Jason T Doherty; Mauricio Rojas; Hilary E Beggs; Louis F Reichardt; Christopher P Mack; Joan M Taylor
Journal:  Circ Res       Date:  2006-08-10       Impact factor: 17.367

5.  Network-based predictions of in vivo cardiac hypertrophy.

Authors:  Deborah U Frank; Matthew D Sutcliffe; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2018-07-17       Impact factor: 5.000

Review 6.  Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy.

Authors:  Abdulhamid Abdi; Shahad AlOtaiby; Firas Al Badarin; Ali Khraibi; Hamdan Hamdan; Moni Nader
Journal:  Biomed Pharmacother       Date:  2021-12-09       Impact factor: 7.419

7.  Cardiomyogenic Differentiation Potential of Human Dilated Myocardium-Derived Mesenchymal Stem/Stromal Cells: The Impact of HDAC Inhibitor SAHA and Biomimetic Matrices.

Authors:  Rokas Miksiunas; Ruta Aldonyte; Agne Vailionyte; Tadas Jelinskas; Romuald Eimont; Gintare Stankeviciene; Vytautas Cepla; Ramunas Valiokas; Kestutis Rucinskas; Vilius Janusauskas; Siegfried Labeit; Daiva Bironaite
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.